March 9, 2026

Cancer has a unique nuclear metabolic fingerprint, researchers discover

March 9, 2026 / Research update / InnovateMed Author / nuclear metabolic footprint

by Center for Genomic Regulation edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Breast cancers (left) show higher nuclear levels of energy-producing enzymes than lung cancers (right), revealing tissue-specific nuclear metabolism. Credit: Alberto Coll Manzano/Centro de Regulación Genómica More than 200 metabolic enzymes, many of which are normally tasked with […]

Cancer has a unique nuclear metabolic fingerprint, researchers discover Read More »

Cheek cells may provide clues to schizophrenia risk

March 9, 2026 / Research update / InnovateMed Author / schizophrenia risk

by Paul Arnold, Medical Xpress edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Sp4 mRNA expression in buccal cells correlates with poorer performance on the recognition portion of the HVLT-R. Credit: Science Advances (2026). DOI: 10.1126/sciadv.aeb0460 A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia.

Cheek cells may provide clues to schizophrenia risk Read More »

This week it’s amylin in the obesity race

March 9, 2026 / News update / InnovateMed Author / obesity race

After a steady stream of GLP-1 data last week, the news kept flowing this week when Sciwind Biosciences got clearance from Chinese regulators for its GLP-1 injectable for obesity. Pfizer will commercialize the drug in that country following a deal last month. But the obesity attention this week was more focused on the amylin front. The mechanism, which some

This week it’s amylin in the obesity race Read More »

How Nanotech Made an Old Leukemia Drug 22,000x Stronger

March 9, 2026 / Research update / InnovateMed Author / leukemia

February 27, 2026 When Chad Mirkin, PhD, asked his graduate students to run a “Friday afternoon experiment” nearly 20 years ago, he wasn’t expecting to affect cancer treatment. He simply wanted to see what would happen if you put spherical nucleic acids (SNAs), a form of DNA he’d invented in 1996, into cell culture. Chad Mirkin,

How Nanotech Made an Old Leukemia Drug 22,000x Stronger Read More »

Docs Land Nearly $400 Million in First Year of Controversial Medicare Billing Code

March 9, 2026 / Clinical Practice / InnovateMed Author / billing code

A long-awaited Medicare add-on billing code not only boosted pay for primary care physicians but also helped specialists, researchers found in a new JAMA study that’s likely to reignite debate over whether the code is working as intended. The analysis of Medicare claims data found that in 2024, its first year of use, the G22111 code was billed 26

Docs Land Nearly $400 Million in First Year of Controversial Medicare Billing Code Read More »

Cancer has a unique nuclear metabolic fingerprint, researchers discover

Cheek cells may provide clues to schizophrenia risk

This week it’s amylin in the obesity race

How Nanotech Made an Old Leukemia Drug 22,000x Stronger

Docs Land Nearly $400 Million in First Year of Controversial Medicare Billing Code

Need Help?

We are here to help.